Incidence of humoral hypercalcemia of malignancy among hypercalcemic patients with cancer
详细信息 查看全文
- 作者：Jeffrey J. Szymanski1 ; Zaher K. Otrock1 ; Khushbu K. Patel ; Mitchell G. Scott ; mscott@path.wustl.edu" class="auth_mail" title="E-mail the corresponding author
- 关键词：Hypercalcemia ; Malignancy ; PTHrP ; Prevalence
- 刊名：Clinica Chimica Acta
- 出版年：2016
- 出版时间：30 January 2016
- 年：2016
- 卷：453
- 期：Complete
- 页码：190-193
- 全文大小：281 K
文摘
- em" id="list_l0005">
- el">•
PTHrP immunoassay results were reviewed over a 12-year period at our institution.
- el">•
Age, race and gender were not associated with humoral hypercalcemia of malignancy (HHM).
- el">•
HHM constituted 38% of hypercalcemia among cancer patients.
- el">•
The prevalence of HHM was lower than previously thought,
- el">•
Elevated PTHrP was present at initial diagnosis of malignancy in 20% of cases.